Inhibition of complement-mediated immune hemolysis by peptides derived from the constant domain of immunoglobulin

Transplantation

Volumn 67, Issue 4, 1999, Pages 637-638

  Kojima, Taiki ^a,b   Del Carpio, Carlos A ^c   Tajiri, Hisao ^d   Yoshikawa, Kazuhiro ^e   Saga, Shinsuke ^e   Yokoyama, Ituo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Surgery   (Japan)

^c TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

^d National Cancer Center   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; GRAFT REJECTION; HEMOLYSIS; HUMAN; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; SERUM; SWINE; XENOTRANSPLANTATION;

EID: 0033608456     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199902270-00027     Document Type: Article

References (9)

1. Magee JC, Frank MM, Platt JL, et al. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest 1995; 96: 2404.
2. Kojima T, Yokoyama I, Takagi H, et al. Role of Fc fragments for inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin. Transplantation 1996; 62: 559.
3. Mollnes TE, Garred P, Harboe M, et al. Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties. Scand J Immunol 1995; 41: 449.
4. Kojima T, Yokoyama I, Takagi H, et al. Inhibition of complement-mediated immune hemolysis by the constant domain of immunoglobulin. Xenotransplantation 1997; 4: 75.
5. Lucas TJ, Munoz H, Erickson BW. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G. J Immunol 1981; 27: 2555.
6. Duncan AR, Winter G. The binding site for C1q on IgG. Nature 1988; 332: 738.
7. Ward ES, Ghetie V. The effector functions of immunoglobulins: implications for therapy. Ther Immunol 1995; 2: 77.
8. Lee JP, Painter RH. Complement binding properties of two peptides from the Cγ2 region of human IgG1. Mol Immunol 1980; 17: 1153.
9. Posnett DN, McGrath H, Tam JP. A novel method for producing anti-peptide antibodies. J Biol Chem 1988; 263: 1719.